Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1960 4
1962 1
1964 1
1966 1
1967 1
1970 1
1972 1
1974 1
1975 1
1981 1
1982 1
1984 2
1985 6
1986 4
1987 3
1988 3
1990 1
1991 6
1992 3
1993 8
1994 5
1995 13
1996 11
1997 10
1998 4
1999 11
2000 7
2001 9
2002 10
2003 9
2004 12
2005 16
2006 15
2007 10
2008 27
2009 16
2010 14
2011 12
2012 9
2013 9
2014 29
2015 28
2016 24
2017 22
2018 21
2019 15
2020 16
2021 14
2022 19
2023 16

Text availability

Article attribute

Article type

Publication date

Search Results

455 results

Results by year

Filters applied: . Clear all
Page 1
Recommendations for the Management of Drug-Drug Interactions Between the COVID-19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications.
Marzolini C, Kuritzkes DR, Marra F, Boyle A, Gibbons S, Flexner C, Pozniak A, Boffito M, Waters L, Burger D, Back DJ, Khoo S. Marzolini C, et al. Among authors: pozniak a. Clin Pharmacol Ther. 2022 Dec;112(6):1191-1200. doi: 10.1002/cpt.2646. Epub 2022 Jun 7. Clin Pharmacol Ther. 2022. PMID: 35567754 Free PMC article. Review.
www.safer-sex.com.
Pozniak A. Pozniak A. Curr Opin Infect Dis. 2001 Feb;14(1):39-40. doi: 10.1097/00001432-200102000-00007. Curr Opin Infect Dis. 2001. PMID: 11979113 No abstract available.
Lopinavir/ritonavir (ABT-378/r).
Qazi NA, Morlese JF, Pozniak AL. Qazi NA, et al. Among authors: pozniak al. Expert Opin Pharmacother. 2002 Mar;3(3):315-27. doi: 10.1517/14656566.3.3.315. Expert Opin Pharmacother. 2002. PMID: 11866671 Review.
HIV Drug Resistance.
Beyrer C, Pozniak A. Beyrer C, et al. Among authors: pozniak a. N Engl J Med. 2018 Mar 1;378(9):875. doi: 10.1056/NEJMc1716089. N Engl J Med. 2018. PMID: 29490186 No abstract available.
Tuberculosis and AIDS.
Drobniewski FA, Pozniak AL, Uttley AH. Drobniewski FA, et al. Among authors: pozniak al. J Med Microbiol. 1995 Aug;43(2):85-91. doi: 10.1099/00222615-43-2-85. J Med Microbiol. 1995. PMID: 7629858 Review.
Sexually transmitted diseases.
Pozniak AL. Pozniak AL. Curr Opin Infect Dis. 2000 Feb;13(1):27-28. doi: 10.1097/00001432-200002000-00005. Curr Opin Infect Dis. 2000. PMID: 11964769 No abstract available.
Resurgence of tuberculosis.
Uttley AH, Pozniak A. Uttley AH, et al. Among authors: pozniak a. J Hosp Infect. 1993 Apr;23(4):249-53. doi: 10.1016/0195-6701(93)90141-l. J Hosp Infect. 1993. PMID: 8099923 No abstract available.
Safety implications of combined antiretroviral and anti-tuberculosis drugs.
Cerrone M, Bracchi M, Wasserman S, Pozniak A, Meintjes G, Cohen K, Wilkinson RJ. Cerrone M, et al. Among authors: pozniak a. Expert Opin Drug Saf. 2020 Jan;19(1):23-41. doi: 10.1080/14740338.2020.1694901. Epub 2019 Dec 6. Expert Opin Drug Saf. 2020. PMID: 31809218 Free PMC article. Review.
455 results